Intravitreal bevacizumab for retinopathy of prematurity in infants ineligible for laser therapy


HONDUR A. M. , Cubuk M. O. , Ozen Tunay Z., ATALAY H. T. , Ozdemir O., Petricli I. S. , ...More

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.46, no.3, pp.764-768, 2016 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 46 Issue: 3
  • Publication Date: 2016
  • Doi Number: 10.3906/sag-1502-65
  • Journal Name: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.764-768
  • Gazi University Affiliated: Yes

Abstract

Background/ aim: To evaluate refractive and strabismic results and the efficacy of intravitreal bevacizumab in retinopathy of prematurity (ROP) ineligible for laser therapy.